Patient Recruitment Resumes in FibroGen Phase 2 Study of ... - Earthtimes (press release) |
|
|
In fact, only 5% of incident dialysis patients have received therapy with Erythropoiesis-Stimulating Agents (ESAs), the primary treatment for anemia of CKD, ... read more
|